Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB)
A completed clinical trial evaluating the performance of vibegron in participants with overactive bladder. The study was sponsored by Urovan…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate) [Phase 4]
Phase 4 post-marketing study assessing the efficacy and safety of solifenacin for overactive bladder in patients after prostate surgery (TUR…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder [Phase 2]
A Phase 2 study evaluating the efficacy and safety of YM178 (mirabegron) for overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study of YM178 in Patients With Symptomatic Overactive Bladder [Phase 2]
A Phase 2 study of YM178 for symptomatic overactive bladder conducted by Astellas has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder [Phase 3]
A Phase 3 clinical trial evaluating YM178 for overactive bladder has completed, with safety and efficacy assessments conducted in patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study of YM178 in Subjects With Symptoms of Overactive Bladder [Phase 3]
Phase 3 trial of YM178 (mirabegron) for overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB) [Phase 1]
This completed Phase 1 pediatric study assessed the pharmacokinetics, safety, and tolerability of Mirabegron oral suspension in children age…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice
A prospective non-interventional study evaluated Betmiga (mirabegron) in routine clinical practice for overactive bladder and urinary incont…
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder [Phase 1]
Phase 1 single-dose pediatric trial to measure blood levels and safety of a drug for overactive bladder and neurogenic detrusor overactivity…
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder [Phase 1]
Phase 1 study assessing pharmacokinetics, safety and tolerability of Mirabegron OCAS in pediatric patients with Neurogenic Detrusor Overacti…
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and Adolescents [Phase 1]
This update details a Phase 1 pharmacokinetic study of solifenacin succinate suspension in children and adolescents with overactive bladder;…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Laser Therapy for Treatment of Urogenital Symptoms in Women
A completed clinical trial evaluated laser therapy for urogenital symptoms in women; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: PTNS for Female Patients Suffering From Multiple Sclerosis [NA]
Terminated clinical trial evaluating percutaneous tibial nerve stimulation (PTNS) in female patients with multiple sclerosis (including over…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Darifenacin x Parasacral Transcutaneous Electric Nerve Stimulation for OAB in Patients Infected With Human T-Lymphotropic Virus 1 [Phase 4]
Phase 4 trial update on combining darifenacin with parasacral transcutaneous electrical nerve stimulation for overactive bladder in HTLV-1 i…
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease [Phase 3]
Phase 3 trial evaluating solifenacin therapy for urinary symptoms in Parkinson disease completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic Bladder [Phase 4]
Phase 4 trial reports on the safety and efficacy of oxybutynin topical gel in children with neurogenic bladder.
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: Botulinum Neurotoxin Type A (BoNT-A) in Paediatric Non-neurogenic Therapy Resistant Overactive Bladder (OAB)
A pediatric study evaluating botulinum toxin type A for non-neurogenic, therapy-resistant overactive bladder has completed; the trial is spo…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia [Phase 3]
Extension Phase 3 study of vibegron for overactive bladder in men on BPH therapy has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: Stress and Anxiety Effects on Overactive Bladder
The clinical trial NCT05087810 at Vanderbilt University Medical Center was terminated while studying the effects of stress and anxiety on ov…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Treatment of REfractory Overactive BLadder With the AXonics Sacral Neuromodulation System (RELAX-OAB) [NA]
The RELAX-OAB clinical trial evaluating the AXonics Sacral Neuromodulation System for refractory overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) [Phase 3]
Phase 3 trial assessing efficacy, safety, and tolerability of vibegron in men with overactive bladder on BPH therapy has completed, with res…
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: Real-life Clinical Experience With Ialuadapter Study
This clinical trial update reports real-world experience with the Ialuadapter, in patients with interstitial cystitis, overactive bladder, a…
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: Urinary Cytokines in Patients With Overactive Bladder (OAB)
A completed clinical trial evaluating urinary cytokines in patients with overactive bladder has posted results as of 2024-07-29. The trial i…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Posterior Tibial Transcutaneous Neurostimulation in Idiopathic Overactive Bladder
This entry reports a completed clinical trial evaluating posterior tibial transcutaneous neurostimulation for idiopathic overactive bladder.
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder [Phase 3]
Phase 3 study evaluating DA-8010 for overactive bladder has completed.